There are several types of dressings for PU prevention available on the market, with the transparent polyurethane film (PF) and hydrocolloid dressings (HD) being the most widely used in Brazil. Besides having technical and scientific knowledge about PUs, health professionals have to consider the population attributable risk and find new, less expensive, efficient and effective resources and technologies appropriate and accessible to patients in Brazil.
At present, the decision whether to use hydrocolloid or transparent polyurethane dressing is not based on scientific evidence, but on the nurse's personal experience and decision. As nursing practice varies widely among institutions and even within the same institution, strong evidence-based guidelines need to be developed to support nursing decision making. 9 The National Pressure Ulcer Advisory Panel (NPUAP) recommends the application of prophylactic dressings to bony prominences (for example, heels, sacrum) for the prevention of PUs in anatomical areas frequently subjected to friction and shear; the procedure should be combined with the use of all other preventive measures. 10 In this study, we compared the performance and effectiveness of HD and PF in preventing PU development. Although some studies have used these technologies for this purpose, no strong evidence was found in the literature to support a less interventionist, evidencebased practice, which may reduce iatrogenic risks. [9] [10] [11] [12] [13] 
Materials and methods
This epidemiological, exploratory, comparative, cross-sectional analytical study was conducted in the Intensive Care Unit (ICU), Coronary Care Unit (CCU) and Medical Clinic of the Holy House of Mercy of Passos, Brazil. The study was approved by the Research Ethics Committee of the Dr. Jose Antonio Garcia Coutinho School of Health Sciences (approval no. 59868) and performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its subsequent revisions. Written informed consent was obtained from all patients or their representatives before inclusion in the study, and anonymity was assured.
Eligibility criteria included adult patients of both sexes, without PUs, hospitalised in the adult ICU, CCU or medical clinic of the institution, at moderate and high-risk of PUs, according to the Braden scale for predicting pressure ulcer risk (Braden scale), assessed l Objective: To compare the performance and effectiveness of a hydrocolloid dressing (HD) and a transparent polyurethane film (PF) in preventing pressure ulcer (PU) development. l Method: The study was conducted in the intensive care unit, coronary care unit and medical clinic of the Holy House of Mercy of Passos, Brazil. Data were collected 48 hours after admission and during hospitalisation. The Braden scale was used for PU risk assessment. Consecutive eligible patients without PUs were randomly assigned by lottery to the two groups, either the HD or PF group. l Results: Of the 160 eligible patients, significant between-group differences were found in the mean total number of dressing changes (HD, 6.09 ± 1.655 changes; PF, 5.59 ± 2.036 changes; p=0.010), and mean number of dressing changes in the sacral region (HD, 2.50 ± 0.871; PF, 2.05 ± 0.825; p=0.001), with the PF group requiring significantly fewer changes than the HD group. The most common reasons for changing dressings in both groups were moisture (PF 51.1%; HD 47.9%) and shear (HD 43%; PF 38.9%), with a significant difference in shear between groups. The incidence of PUs was significantly lower (p=0.038) in the PF group (8.7%) compared with that in the HD group (15%). l Conclusion: The results suggest that the transparent polyurethane film had a better performance and was more effective than the hydrocolloid dressing in preventing PU development. l Declaration of interest: All authors declare that no competing financial interests exist. There was no external funding for this study. 48 hours after admission. Exclusion criteria were patients with PUs, and those hospitalised for less than 48 hours, who died or were diagnosed as brain death, and those who dropped out, declined or whose family members declined to participation in the study. Consecutive patients without PUs who were admitted to the study units and met inclusion criteria were randomly assigned by lottery (drawing from a sealed envelope) to two groups: the PF group, who received the transparent polyurethane film (OpSite, Smith and Nephew Ltd., Hull, UK), and the HD group, who received a hydrocolloid dressing (Systagenix Wound Management Ltd., Vinhedo, Brazil).
Data collection was performed at the time of patient inclusion (baseline) and during hospitalisation, consisting of physical examination, assessment of risk factors for PU development, and application of the Braden scale. Data were collected by nurse specialists in enterostomal therapy, with more than 10 years of experience in the field. Risk of PU development and presence of PUs were assessed by a daily physical examination of the patient skin and application of the Braden scale for 30 consecutive days or until the patient was discharged, transferred, or died.
The Braden scale was chosen because it had been translated and validated for the Brazilian population and shows good accuracy, through good levels of sensitivity, specificity and positive and negative predictive validity.
14 The Braden scale is composed of six subscales assessing sensory perception, activity, mobility, moisture, nutrition, and friction and shear. Each subscale is rated from 1 to 4, except friction and shear, which is rated from 1 to 3. The sum of the ratings gives a total risk score ranging from 6 to 23, with lower scores indicate higher risk. Incremental changes in the score indicate the level of risk: no risk, 19-23; at risk, 15-18; moderate risk, 13-14; high risk, 10-12; and very high risk, 9 or below. 14 The dressing was applied bilaterally to the trochanteric and sacral regions in all patients at moderate-and high-risk of PUs. Dressings were changed only if there was loss of adhesiveness, shear, excessive moisture, friction, presence of wrinkles, or the combination of these factors.
The effectiveness and performance of the dressings were evaluated by the incidence of PUs in each group, reasons for dressing changes, mean number of dressing changes per body region, and total number of dressing changes during the study period.
Incidence of PUs was expressed in percentage and calculated as: Incidence = (number of patients who developed PUs)/(number of patients at risk of PUs)×100
Statistical analysis
Data were entered into an Excel spreadsheet (Microsoft Corporation, WA, USA) using double data entry to prevent error. Statistical analysis was carried out using the EPI-Info software (Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA).
The chi-square test was used to test for associations between demographic characteristics (sex, age and smoking habit), Braden scale scores, reason for dressing changes, number of dressing changes and frequency of changes. Fisher's exact test was used when the chi-square test was inappropriate. Statistical significance was set at a level of 0.05. 
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Results
Of the 160 patient recruited, the mean age was 65.15 and 64.13 years in the PF and HD groups, respectively. In both groups, most patients were men (PF n=44, 55%; HD n=47, 58.8%), caucasian (PF n=65, 81.2%; HD n=73, 91.2%), and smokers (PF n=64, 80%; HD n=56, 70%). Despite randomisation, there were significantly more Caucasians and less Afro-Brazilians and mixed-race patients in the HD group than in the PF group (p = 0.023; Table 1 ). The majority of patients in both groups were on mechanical ventilation, receiving vasoactive drugs, unconscious, fasting, and had urinary or faecal incontinence and psychomotor agitation ( Table 2) . Significant differences in psychomotor agitation (PF n=60, 75%; HD n=71, 88.8%; p=0.024), level of consciousness (PF n=44, 55%; HD n=49, 61.2%; p=0.036), and nutritional state (PF n=50, 62.5%; HD n=78, 97.5%; p=0.001) were found between groups ( Table 2 ).
All study participants were at moderate or high risk of PUs (Braden score between 9-14), and most patients in both groups were at high-risk of PUs, showing Braden total scores from 10-12 (both groups, n=73, 91.2%; Table 3 ). However, if you look closely to the high-risk category (Table 3) , you will notice a significant difference between groups (p=0.028) in the number of patients with Braden scores of 10 and 11 (Braden score=10: HD group=27.5% versus PF=13.7%; Braden score=11: HD group=61.2% versus PF group=75.0%).
The most common reasons for changing dressings in both groups were moisture (PF 51.1%; HD 47.9%) and shear (HD 43%; PF 38.9%), with a significant between-group difference in shear (p=0.048; Table 4 ).
HDs were first changed after 2 days in 13 (16.3%) patients and after 7 days in 21 (26.3%) patients. PFs were first changed after 5 days from baseline in 23 (28.7%) patients and after 10 and 12 days in 34 (42.5%) and 11 (13.8%) patients, respectively. Significant between-group differences were found in the mean total number of dressing changes (HD 6.09 ± 1.655 changes; PF 5.59 ± 2.036 changes; p=0.010), and mean number of dressing changes in the sacral region (HD 2.50 ± 0.871 changes; PF 2.05 ± 0.825 changes; p=0.001), with PF requiring significantly fewer changes than the HD group (Table 5) .
The incidence of PUs was significantly lower (p=0.038) in the PF group (8.7%) than in the HD group (15%).
Discussion
In this study, most participants were men, aged over 60 years old, caucasians, and smokers, which is in agreement with the profile of patients in previous studies on PUs. 5, [15] [16] [17] The skin of elderly people produces less collagen and has reduced elasticity, blood circulation and peripheral sensitivity, decreasing the skin's tolerance to shear stress, and increasing the risk of PUs. 18 Smoking also increases the risk of PUs; it may induce vasoconstriction (reducing subcutaneous oxygen tension for more than 45 minutes after a cigarette), and reduce appetite (causing multiple vitamin deficiency) and collagen synthesis. 19 The overall incidence of PUs was 11.9%. A study on PUs reported an incidence of 3.6% in patients hospitalised in a surgery unit, neurological unit, and ICU of an emergency and urgent care centre in Brazil. 20 while another study conducted in Japan, involving 105 patients from an ICU, found an incidence of PUs of 33%.
21
A non-randomised controlled trial evaluated the effectiveness of PF dressing in preventing PUs on the heel of 100 patients, who received PF and clinical intervention on the left heel and clinical intervention only (no dressings) on the right heel. 11 The overall incidence of PUs was 32%, with 6% occurring in the left heel (PF), 18% in the control heel, and 8% bilaterally, with a significant impact after the first 15 days of hospitalisation. 11 In the present study, the incidence of PUs was significantly lower (p=0.038) in the PF group (8.7%) than in the HD group (15%), suggesting that PF may be more effective in preventing PUs than the HD. It was also observed that the PF required significantly fewer changes (p=0.010), especially in the sacral region (p=0.001), compared with the HD. In addition, the HD group required earlier changes compared with the PF group. These results suggest a better performance of the transparent polyurethane film compared with the hydrocolloid dressing.
The PF is a synthetic, adhesive and hypoallergenic material. It is inactive in the presence of moisture, having a system of gas exchange similar to the healthy skin, which allows the diffusion of gases, such as oxygen and vapours. It has an elastic quality that allows it to be applied to different parts of the body and resist to friction and shear forces.
10, 13 The PF is impermeable to fluids, secretions and bacteria. The permeability of a dressing (the amount of moisture vapour that passes through the dressing membrane at a given period of time) is measured by the moisture vapour transmission rate (MWTR). 22 The higher the MWTV, the more effectively moisture is removed, /day, and a 'high permeability' film dressing has a transmission rate of 3000g/m 2 /day and higher, and is indicated for use in intravenous sites. 13, 22 It is important to highlight that patients should be assessed for risk of PUs not only at admission, but every day, especially after clinical changes. Dressings applied to bony prominences may help preventing PU development in anatomical areas frequently subjected to friction and shear. However, all other preventive measures should also be used.
Limitations
The study was limited by lack of a control group (a group of patients not using dressings as a preventive measure for PU development). Despite randomisation, there were significant differences between groups in ethnicity, psychomotor agitation, level of consciousness, and nutritional state. There was also a significant between-group difference in the number of patients with Braden total scores of 10 and 11 within the 'high risk' category for PU development, with the HD having more patients with the higher risk score of 10. However, the distribution of patients among risk categories was comparable.
Conclusion
In this study, we compared the performance and effectiveness of HD and PF in preventing PUs. We found that dressing changes in the PF group were significantly less affected by shear than were changes in the HD group. The HD required earlier and significantly more changes than PF, especially in the sacral region. Patients who received the PF had a significantly lower incidence of PUs (8.7%) than those who received the HD (15%). These results may suggest that the PF had a better performance and was more effective in preventing PUs compared with the HD. n
